https://www.selleckchem.com/products/blu-945.html
4 percentage point reduced risk of relapse [95% confidence interval (CI)=-12.0, 5.3] comparing XR-NTX to BUP-NX (explaining 21% of the total effect). For the non-homeless subgroup, the indirect path contributed a 9.4 percentage point increased risk of relapse (95% CI=3.1, 15.7) comparing XR-NTX to BUP-NX (explaining 57% of the total effect). A novel approach to mediation analysis shows that much of the difference in medication effectiveness (extended-release naltrexone versus buprenorphine-naloxone) on opioid relapse among non-homeless
Like
Comment
Share
